11 Nov 2022 --- The nutraceutical ingredient could help to reduce lung inflammation, restore respiratory health and reduce lung scarring caused by eosinophilic asthma, a new study reveals. Human trials are in the pipeline following this study that was conducted on mice. The company further states that studies to assess the possible effects of OmeGo on chronic obstructive pulmonary disease, pollution-induced lung inflammation and gut health are also in the works.
